One of the projects is focused on helping patients with genetic disorders that weaken bones and make it more difficult to recover after bone fractures and surgery. The researchers will test a new material to mimic the body’s natural collagen that would ultimately correct the genetic defects.
Pediatric geneticist Dr. Michael Bober and pediatric orthopedic surgeon Richard Kruse, MD, are working on the project with April Kloxin. Both Dr. Bober and Dr. Kruse are looking for a way to promote bone regeneration among children with osteogenesis imperfecta.
More articles on orthopedic devices:
12 observations on implant materials for the next generation
16 spine devices receive FDA 510(k) clearance in March
Zimmer voluntarily recalls knee device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
